Efficacy of TNF α inhibitors for refractory vascular Behçet's disease: A multicenter observational study of 27 patients and a review of the literature

ConclusionTumor necrosis factor ‐alpha inhibitors seem a highly effective option for remission‐induction of refractory VBD with an acceptable safety data. Concomitant IS use may achieve higher complete remission rates as compared to TNFα inhibitor monotherapy. Comparative efficacy and safety of biological agents for VBD requi re further prospective, randomized controlled studies with a longer duration of follow‐up.

Source: International Journal of Rheumatic Diseases - January 23, 2020 Category: Rheumatology Authors: Aysun Aksoy, Ayten Yazici, Ahmet Omma, Ayse Cefle, Fatos Onen, Unal Tasdemir, Tulin Ergun, Haner Direskeneli, Fatma Alibaz ‐Oner Tags: ORIGINAL ARTICLE Source Type: research